Refine search

Search Substrates and Products (Substrate)

Substrates and Products (Substrate): show results

Don't show organism specific information (fast!)

Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)

(Not possible to combine with the first option)

Refine your search

Recommended Name:

EC Number:

Commentary Substrates:

Literature (Substrates):

Organism:

Products:

Commentary (Products):

Reversibility:

Search term:

Results 1 - 10 of 14

EC Number	Substrates	Commentary Substrates	Organism	Products	Commentary (Products)	Reversibility
1.1.1.387	3-hydroxypropionate + NAD+	-	Pyrobaculum calidifontis	? + NADH + H+	-	?
1.1.1.387	D-glycerate + NAD+	-	Pseudomonas aeruginosa	?	-	?
1.1.1.387	DL-3-hydroxyisobutyrate + NAD+	-	Pyrobaculum calidifontis	? + NADH + H+	-	?
1.1.1.387	DL-glycerate + NAD+	-	Pyrobaculum calidifontis	? + NADH + H+	-	?
1.1.1.387	DL-threonine + NAD+	-	Pseudomonas aeruginosa	?	-	?
1.1.1.387	L-serine + NAD(P)+	-	Pyrobaculum calidifontis	2-aminomalonate semialdehyde + NAD(P)H + H+	-	?
1.1.1.387	methyl 2,2-dimethyl-3-hydroxypropionate + NAD+	-	Pseudomonas aeruginosa	?	-	?
1.1.1.387	more	modeling of the D-serine and 3-hydroxypropionate molecules into the enzyme's active site. No steric hindrance is observed between D-serine and the side chains of the active site residues. D-serine is placed at the position through interactions similar to the L-serine binding model. The C3 hydrogen of D-serine is located at the same position as that of L-serine. This may explain the high reactivity toward D-serine exhibited by Pyrobaculum calidifontis L-SerDH	Pyrobaculum calidifontis	?	-	-
1.1.1.387	D-serine + NAD+	overall reaction, 5% of the relative activity observed with L-serine	Pyrobaculum calidifontis	2-aminoacetaldehyde + CO2 + NADH + H+	-	?
1.1.1.387	L-serine + NADP+	overall reaction, low activity with NADP+	Pyrobaculum calidifontis	2-aminoacetaldehyde + CO2 + NADPH + H+	-	?

Results 1 - 10 of 14

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)